- Iowa dentist disciplined for unsanitary practice conditions
- ADA honors 10 new dentists for excellence in field
- Orthodontist pay vs. cost of living by state
- Oral surgeon pay vs. cost of living by state
- Wildfire smoke strafes Midwest, Northeast: 6 things healthcare leaders should know
- 9 pharmacy groups warn revised ACIP charter could delay vaccine access: 6 notes
- Private equity’s legal playbook for physician practices
- The outpatient orthopedic model built around doing less
- Where ASCs can find cost savings after the easy wins are gone
- NYU Langone grows South Florida presence with 2 practices
- The hidden cost of the GLP-1 boom: 5 notes
- ‘Hospitals without an outpatient footprint will struggle’: Health systems race to build ASC networks
- ‘Hospitals without an outpatient footprint will struggle’: Health systems race to build ASC networks
- Montefiore leader joins Northwell hospital as CNO, VP of patient care services
- Bad debt, charity care surge continues to squeeze hospitals
- 3 cardiology societies urge CMS to update TAVR coverage rules: 5 priorities
- UCSF nurses, physicians protest ED ‘boarding crisis’
- Inova’s next clinical chief keeps a fish pillow in her office
- Missouri outlaws insurance time limits on anesthesia: 5 things to know
- Texas hospital temporarily closes due to flooding
- Trump’s CDC Nominee Praises Vaccines, Without Vowing Independence From Kennedy
- Why ASCs should be watching the Medicare Advantage exodus
- LightForce Orthodontics appoints new CEO
- 39 behavioral health executive moves to know
- Good news for anesthesia
- MAX Surgical Specialty Management selects Sensei Cloud as enterprise practice management system
- Why some ASCs ‘are going to be left out’ of healthcare’s next era
- Median pay for anesthesiologists reaches $391K: Breakdown by state
- Is dental school becoming unattainable? 6 dentists weigh in
- Peak Dental Services becomes 1st DSO to deploy clinician well-being framework
- Aspen Dental continues expansion with South Carolina practice
- Texas safety net behavioral health provider projects $15M shortfall
- 4 dental deals totaling $308M
- Huahai poaches quality chief from Hengrui amid FDA manufacturing citations
- 24 new behavioral health study findings to know
- Maryhaven CEO steps down amid financial concerns
- GE HealthCare, Catholic Health strike 10-year, $500M technology partnership
- Thriveworks launches insight dashboard for referring providers
- What’s driving Arizona’s drug death surge? 6 things to know
- CMS proposal to block third-party vendors will upend remote monitoring services, health tech leaders say
- FDA Clears First Cholesterol Pill, Lipfendra, To Rival Costly Injections
- Statement on Regulation E-Delivery
- Paper Taper: Statement on Proposed Regulation E-Delivery
- Statement on Proposed Regulation E-Delivery
- One Of The Largest Epidural Studies Ever Delivers Reassuring News For Parents
- Bipartisan Senate bill seeks to build vigilance around foreign companies making drugs in US
- Coalition for Health AI launches implementation initiative for public health agencies
- Vanda shifts Nereus marketing into high gear with Schumacher IndyCar sponsorship
- Could A Vaccine Prevent Pancreatic Cancer In Those At High Risk?
- Heatwaves During Pregnancy Could Affect Baby's Brain Development, Study Suggests
- Brain 'Microstimulation' Works Long-Term To Restore Sense Of Touch After Spinal Cord Injury
- Otters, bears and Pharma Lions: inside Gilead’s bronze-winning Cannes spot
- 'Night Owls' At Risk Of Wider Waistlines, Unhealthy Hearts
- Facing Funding Losses, States Call Out Big Businesses With Employees On Medicaid
- Listen to the Latest ‘KFF Health News Minute’
- Readers Share Personal Insights on Deadly Denials and Pregnancy Centers
- A Sales Tax on Doctor Visits and Medicine? In Missouri, Some Worry
- Merck scores at FDA as Lipfendra becomes world's first oral PCSK9 treatment
- UnitedHealth Group to maintain 'restless' even after topping investor's Q2 expectations, CEO says
- 6 weeks into California’s psychiatric staffing mandate: What hospital leaders should know
- The best opportunities to expand behavioral healthcare access
- PsychPlus acquires Koa Health to scale mental health platform
- Senate HELP committee grills CDC nominee Erica Schwartz on vaccine policy, resistance to political interference
- 2 states join in expanding psychologist prescribing authority
- Ohio behavioral health clinic owners indicted in $9.3M Medicaid fraud case
- Bipartisan House bill tying doc pay to inflation earns resounding applause from providers
- West Tennessee Healthcare expands critical care support through eICU Program in partnership with Philips and hellocare.ai
- Sanofi opens new chapters in Pfizer, Moderna mRNA patent litigation sagas
- Novo gains head start on Lilly with European Commission approval of Wegovy pill
- Merck touts Keytruda front-line win in endometrial cancer subtype, marking a PD-1 first
- Wildfire Smoke Puts Millions At Risk Across Midwest, Northeast
- Lark Health, Samsung team up on AI-powered health coach for U.S. seniors
- 340B drug purchases hit at least $100B in 2025, administrator reports
- Buzzy Veradermics shows its oral minoxidil can tackle female pattern hair loss, too
- No patent protection for Stelara? No problem for J&J as Tremfya fills the void
- Amazon Pharmacy partners with eNavvi to provide real-time medication pricing, delivery info to providers
- Are Microplastics Linked To Higher Heart Attack Risk?
- Impulsivity In Third Grade Could Point To Future Struggles
- AI Can Create 'Ghosts' Of Lost Loved Ones, But Would You Want To Meet Them?
- Blood Test May Predict Alzheimer's Risk Up To 10 Years Before Symptoms Begin
- Kelun scores sac-TMT win in first-line NSCLC population missing from Merck’s massive phase 3 program
- OpenAI’s health AI chief: ‘Bet on the models getting better’
- Knee Pain? Ragged Cartilage? Research Suggests Surgery's Not The Best Answer
- THC/CBD Combo Might Ease Agitation In Late-Stage Dementia
- Facing Funding Losses, States Call Out Big Businesses With Employees on Medicaid
- Full-body scan startup Neko Health scores $700M to break into the U.S. market
- Elevance Health leaves D.C. Medicaid market, mulls future exits
- Sanofi teams up with Special Olympics Unified Football World, raises respiratory health awareness
- Insilico signs on with CDMO Bora in $2.5B AI drug discovery deal
- CMS proposes major Medicare reforms to shift physician pay, phase out MIPS and expand ACO participation
- Judi Health rebrands PBM arm as Judi Rx, unveils Judi Care unit
- With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma
- Anthropic bets bigger on healthcare with Optum tie-up, UST integration
- FTC, CVS unveil settlement in ongoing insulin pricing case
- HHS promises its final rule barring pediatric gender care providers from Medicare is still coming
- Director's Note on What to Expect at the 2026 Partnerships with Sites Summit
- AMA interoperability initiative brings structured clinical terminology to CPT codes
- Lettuce Suspected In Growing Multistate Cyclospora Outbreak
- Startup Sonata launches preventive healthcare membership, linking clinical decisions with AI
- Why Are Family Doctors Leaving The Workforce? Retirement, Burnout Creating A U.S. Primary Care 'Brain Drain'
- Huyabio scores with Opdivo combo in 'milestone' skin cancer trial
- Unruly Patients Are Stressing ER Staff, Undermining Care
- Pain Patients Should Taper Opioids At Their Own Pace, Study Suggests
- Heatwaves Raise Hospital Admissions For Mental Health Woes
- U.S. Gun Suicides Hit Record High, Even As Firearm Deaths Decline Overall
- AstraZeneca pays up to $1.5B for EGFR lung cancer drug Zegfrovy from its spinoff Dizal
- Worried About Your Aging Parents? Welcome To The Caregiving Club
- Lawmakers Look To Make Abortion Shield Laws Less Dependent on Who’s Governor
- Knee Pain? Ragged Cartilage? Research Suggests Surgery’s Not the Best Answer
- Real Chemistry builds body of AI healthcare commercialization tools with Anatomi launch
- Inside agency view: Havas SO on authenticity, connection and pushing back against the ‘sea of sameness’
- Cellares' recent automated cell therapy wins have 'opened the biotech floodgates'
- Insulet, Calm join forces for diabetes care offerings with ‘Mind in Range’ wellness tools
- Remarks before the American-Hellenic Chamber of Commerce
- What Is An Aortic Dissection? The Condition That Killed Sen. Lindsey Graham
- Weight-Loss Drugs Help, But Exercise Is Still The Key To A Healthier Heart
- FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny
- GSK to seek FDA approval for Jemperli in small but high-profile cancer use after phase 2 win
- Smartphones Can Increase Seniors' Risk Of Depression
- Pro Soccer Players Show Signs Of Shrinking Brains
- Adderall Misuse Falls Sharply Among Young Adults, Study Finds
- New KFF Poll Reveals Who Is Most Likely To Endorse Vaccine Myths
- A New Option For Long-Term Care Costs
- As GOP Cries Fraud, Newsom Backs Medicaid Spending on Housing and Food
- Lupin recalls more than 2.5M prescription eye drop bottles, citing possible contamination
- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- A New Option for Long-Term Care Costs
- Remarks at the Society for Corporate Governance Conference
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Statement on the 2026 Regulatory Agenda
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- SCAN Health Plan, Alignment Healthcare sue to challenge CMS' MA star ratings recalculations
Michigan healthcare freedom community forum
The National Vaccine Injury Compensation Program (VICP or NVICP) was established by the 1986 National Childhood Vaccine Injury Act (NCVIA) which was a response to concerns about the diphtheria, pertussis, and tetanus (DPT) vaccine. The Office of Special Masters of the U.S. Court of Federal Claims administers a no-fault system for litigating vaccine injury claims - except for the COVID-19 vaccines. People claiming injuries from the COVID-19 vaccines have to file a claim with the Countermeasures Injury Compensation Program (CICP). Both the NVICP and the CICP are part of the Health Resources & Services Administration (HRSA), but the claims outcomes have been quite different:
Lawsuit: COVID Vaccine Injury Claims Diverted to Unconstitutional 'Kangaroo Court'
A war on terror–era program is the only legal avenue for people seeking compensation for a COVID vaccine injury.
By Christian Britschgi | November 21, 2023People injured by the COVID-19 vaccines are suing the federal government, claiming the federal program they're forced to pursue compensation through is an opaque and unconstitutional "kangaroo court" that unjustly rejects almost all claims it receives.
"It has become far more obvious that the program offers nothing close to due process," says Christopher Dreisbach, the legal affairs director for React19, a patient group of the vaccine injured. "There's not [just] one thing about the program that can be tweaked and be fixed."
React19 is one of several plaintiffs challenging the constitutionality of the Countermeasures Injury Compensation Program (CICP). The other plaintiffs are all individuals whose compensation claims were rejected by the CICP, despite many having diagnoses from their doctors that the severe injuries they experienced within a few hours or days of receiving a COVID-19 vaccine were a result of the vaccine.
Their lawsuit was filed in October in the U.S. District Court for the Western District of Louisiana.
The CICP is currently the only avenue through which those with a COVID-19 vaccine injury can seek compensation.
A mix of federal law and pandemic-era emergency declarations bar the vaccine injured from suing vaccine manufacturers in civil court. Those with a COVID-19 vaccine injury are also prohibited from pursuing compensation through the standard Vaccine Injury Compensation Program (VICP)—a decades-old program that approves about 50 percent of injury claims in an expedited civil court–like process.
Each year, the VICP paid out $200 million in compensation and attorneys' fees, all of which are funded by an excise tax on vaccines.
Contrast that with the CICP, which has paid out a total of around $30,000 compensating eight people claiming a COVID-19 vaccine injury.
That's out of 12,358 total COVID-related claims the CICP has received, according to the latest federal data. The vast majority of those claims are still pending review. Of the 1,600 claims that the CICP has decided, roughly 98 percent were rejected.
The lawsuit filed by React19 and other patients argues the CICP's high rejection rate is a product of a flawed design that includes an exceedingly short deadline for filing for compensation and an impossibly high burden of proof for showing an injury was caused by a vaccine.
People must file a CICP claim within one year of vaccination. That compares to the VICP deadline that gives people three years following the onset of vaccine injury symptoms to file a petition.
"Most of us don't know what's wrong with us for over a year if we can ever get a diagnosis," says Dreisbach, who himself suffered a COVID-19 vaccine injury. "So many in our community don't even know the program even exists."
Of the 1,588 claims CICP has rejected, 933 of them have been for missed deadlines.
In order to get compensation through the CICP, claimants must also show "compelling, reliable, valid, medical, and scientific evidence" that their injury was caused by a COVID-19 vaccine.
By comparison, the VICP has a pretty low threshold for proving a vaccine injury. People who suffered one of several listed "table" injuries soon after receiving their vaccine are presumed to have been injured by the vaccine. Those who suffer a nontable injury need only show by a preponderance of the evidence (i.e., that it's more likely than not) that they were injured by a vaccine.
The higher burden of proof claimants must show the CICP is compounded by the fact that less scientific evidence exists about the effects of the recently invented COVID-19 vaccines.
"When you're talking 40,000 to 60,000 in a study, we know pretty well short-term side effects, but we don't have very much of an idea of what the long-term side effects will be," says Katharine Van Tassel, a law professor at Case Western Reserve School of Law who co-authored a book on the Food and Drug Administration.
Van Tassel says that while vaccines are safe, "we did not have very much time to study [COVID] vaccines, so we know the risk of injury was higher."
The CICP's high burden of proof is compounded by the fact that it's also a purely administrative process, with few guaranteed rights for those seeking compensation. Federal bureaucrats review and decide claims on their own. Claimants have no right to a lawyer to argue their case against the government, no right to submit expert evidence, and no right to appeal a rejected claim to any court.
That all contrasts with the quasi-judicial VICP, where petitioners are guaranteed a lawyer who can submit expert evidence on their behalf and a neutral special master (judge) decides cases. People in the VICP can also appeal a rejected petition all the way up to the U.S. Supreme Court. If that doesn't work, they can then sue vaccine makers in civil court.
In addition to all these problems is the fact that the CICP was, prior to COVID, a little-used program that's arguably been swamped by the huge number of claims it's received.
The CICP was first authorized in 2005 by a piece of war-on-terror legislation intended to encourage companies to produce emergency countermeasures to a bioweapons attack or a similar disaster by shielding them from lawsuits.
Prior to the pandemic, it had received only 500 claims and paid out compensation to only 30 people (mostly for swine flu vaccine injuries).
Van Tassel says that the government is within its powers to suspend people's normal right to sue companies for damages, provided that it also provides anyone claiming an injury "a reasonable alternative remedy" to sue for damages.
The CICP's high standard of proof, short filing deadlines, and lack of any real procedural rights all cause it to fall woefully short of being a "reasonable alternative remedy," she says.
The claims in the lawsuit from React19 and other plaintiffs that the CICP violates the Fifth and Seventh Amendments' guarantees of due process and jury trials are on firm ground, she says. "I think this is a very strong lawsuit," she tells Reason.
There are various congressional efforts to help those with COVID-19 vaccine injuries.
Rep. Lloyd Doggett (D–Texas) has introduced two bills that would shift COVID-19 vaccine injury claimants into the VICP and then modernize the VICP process. Another much more modest bill proposed by Sen. Robert Casey (D–Penn.) would extend the deadline for filing COVID-19 vaccine injury claims.
Last year, Sen. Mike Lee (R–Utah) also introduced a bill that would reform the CICP to make it more like the VICP program, with special masters deciding cases in federal claims court.
None of these efforts have made much headway in Congress, much to the frustration of vaccine-injured advocates.
"Our community needed help yesterday. We've been asking Congress to take action for over two years, our hope is that this lawsuit forces their hand," says Dreisbach.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























